文献
J-GLOBAL ID:202202266924707622
整理番号:22A0562408
MOST(卵巣症状および治療懸念)を用いた卵巣癌に対する第一選択化学療法完了後の患者報告症状および遅発性副作用の評価【JST・京大機械翻訳】
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)
著者 (15件):
Beesley Vanessa L.
(Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Beesley Vanessa L.
(School of Nursing, Queensland University of Technology, Brisbane, Australia)
,
Ross Tanya L.
(Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
King Madeleine T.
(School of Psychology, University of Sydney, Sydney, Australia)
,
Campbell Rachel
(School of Psychology, University of Sydney, Sydney, Australia)
,
Nagle Christina M.
(Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Obermair Andreas
(Queensland Centre of Gynaecological Research, Royal Brisbane and Women’s Hospital, Brisbane, Australia)
,
Grant Peter
(Gynaecological Oncology Department, Mercy Hospital for Women, Melbourne, Australia)
,
DeFazio Anna
(Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia)
,
DeFazio Anna
(Faculty of Medicine and Health, The University of Sydney, Sydney, Australia)
,
DeFazio Anna
(Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia)
,
Webb Penelope M.
(Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Webb Penelope M.
(School of Public Health, The University of Queensland, Brisbane, Australia)
,
Friedlander Michael L.
(Prince of Wales Clinical School, University of New South Wales, Sydney, Australia)
,
Friedlander Michael L.
(Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
164
号:
2
ページ:
437-445
発行年:
2022年
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)